SEC Form 4 · accession 0001209191-18-042325

INTEGRA LIFESCIENCES HOLDINGS CORP · IART

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jul 9, 2018

Accepted (ET)

Jul 11, 2018 · 4:22 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000917520

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 9, 2018	M	120,100	$21.12	A	1,539,019	D
Common Stock^F2	Jul 9, 2018	S	120,100	$64.08	D	1,418,919	D
Common Stock	Jul 10, 2018	M	39,652	$21.12	A	1,458,571	D
Common Stock^F3	Jul 10, 2018	S	39,652	$63.79	D	1,418,919	D
Common Stock	holding	—	—		—	608,700	I	By GRAT

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F5,F4	$21.12	Jul 9, 2018	M	120,100	D	—	Aug 14, 2018	Common Stock	120,100	140,876	D
Non-Qualified Stock Option (right to buy)^F4	$21.12	Jul 10, 2018	M	39,652	D	—	Aug 14, 2018	Common Stock	39,652	101,224	D

F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2The price shown above represents the weighted average price of the shares sold. The range of sale prices was $64 to $64.40
F3The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.50 to $64.44.
F425% of the option grant vested on 8/14/2009 (the first anniversary of the grant date of 8/14/2008), and the remaining 75% vested monthly thereafter over 36 months.
F5This stock option was previously reported as covering 130,488 shares of common stock at an exercise price of $42.24 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.